NHE7介导高尔基体酸化调控胰腺癌细胞胞质pH稳态
该研究在胰腺导管腺癌(PDAC)中鉴定NHE7为胞内pH(pHi)的新型调控因子。NHE7抑制导致高尔基体碱化、胞质酸积聚,主要通过肌动蛋白失调削弱肿瘤细胞适应性;体内敲低NHE7可抑制肿瘤生长,提示高尔基体酸化是控制pHi的机制及PDAC潜在治疗脆弱点。
要点
- NHE7抑制使高尔基体碱化并导致胞质酸积聚,损害PDAC细胞适应性。
- NHE7敲低在体内可抑制肿瘤生长。
- 高尔基体酸化作为「质子池」调控pHi,是PDAC潜在治疗靶点。
核心结论
- NHE7通过高尔基体酸化调控胞质pH稳态,其抑制可削弱PDAC细胞活力并抑制肿瘤生长。
- 高尔基体作为代谢酸的「质子池」,调控pHi可能是PDAC的治疗脆弱点。
研究设计与样本
- 研究在胰腺导管腺癌(PDAC)中鉴定并功能表征钠氢交换体NHE7对胞内pH的调控。
主要发现
- NHE7抑制导致高尔基体碱化,引起胞质酸积聚。
- 胞质酸积聚主要通过肌动蛋白失调削弱肿瘤细胞适应性。
- 体内敲低NHE7可抑制肿瘤生长。
临床怎么用
- NHE7及高尔基体酸化通路可作为PDAC潜在治疗靶点进行后续转化研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cancer cells reprogram their metabolism to meet elevated energy demands and favor glycolysis for energy production. This boost in glycolytic flux supports proliferation, but also generates acid in the form of hydrogen ions that must be eliminated from the cytoplasm to maintain the alkaline intracellular pH (pHi) associated with transformation. To cope with acid production, tumor cells employ ion transport systems, including the family of sodium-hydrogen exchangers (NHE). Here, we identify NHE7 as a novel regulator of pHi in pancreatic ductal adenocarcinoma (PDAC). We determine that NHE7 suppression causes alkalinization of the Golgi, leading to a buildup of cytosolic acid that diminishes tumor cell fitness mainly through the dysregulation of actin. Importantly, NHE7 knockdown in vivo leads to the abrogation of tumor growth. These results identify Golgi acidification as a mechanism to control pHi and point to the regulation of pHi as a possible therapeutic vulnerability in PDAC. SIGNIFICANCE: NHE7 regulates cytosolic pH through Golgi acidification, which points to the Golgi as a "proton sink" for metabolic acid. Disruption of cytosolic pH homeostasis via NHE7 suppression compromises PDAC cell viability and tumor growth.See related commentary by Ward and DeNicola, p. 768.This article is highlighted in the In This Issue feature, p. 747.
引用
- Galenkamp KMO, Sosicka P, Jung M, et al. Golgi Acidification by NHE7 Regulates Cytosolic pH Homeostasis in Pancreatic Cancer Cells. Cancer Discov. 2020. PMID: 32200349. doi:10.1158/2159-8290.CD-19-1007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。